Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells: Laboratory investigation

Journal of Neurosurgery

Volumn 114, Issue 6, 2011, Pages 1681-1690

  Sukumari Ramesh, Sangeetha ^a   Singh, Nagendra ^a   Jensen, Michael A ^a   Dhandapani, Krishnan M ^a   Vender, John R ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anacardic acid; Cell cycle; Histone acetyltransferase; Histone deacetylase; Pituitary tumor; Radiation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANACARDIC ACID; LIPOCORTIN 5; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HYPOPHYSIS ADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

ANACARDIC ACIDS; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; FLOW CYTOMETRY; MICE; PITUITARY GLAND; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79958018870     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.12.JNS10588     Document Type: Article

References (43)

1. Allfrey VG, Mirsky AE: Structural modifications of histones and their possible role in the regulation of RNA synthesis. Science 144:559, 1964
2. Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK: Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278:19134-19140, 2003 (Pubitemid 36799302)
3. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al: Curcumin, a novel p300/ CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279:51163-51171, 2004 (Pubitemid 40017859)
4. Bandyopadhyay K, Banères JL, Martin A, Blonski C, Parello J, Gjerset RA: Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization. Cell Cycle 8:2779-2788, 2009 (Erratum in Cell Cycle 9:1023, 2010)
5. Carew JS, Giles FJ, Nawrocki ST: Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 269:7-17, 2008
6. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, et al: Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23:7494-7506, 2004 (Pubitemid 39389691)
7. Dhandapani KM, Mahesh VB, Brann DW: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102:522-538, 2007 (Pubitemid 47000605)
8. Eliseeva ED, Valkov V, Jung M, Jung MO: Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 6:2391-2398, 2007 (Pubitemid 47480404)
9. Grazzini R, Hesk D, Heininger E, Hildenbrandt G, Reddy CC, Cox-Foster D, et al: Inhibition of lipoxygenase and prostaglandin endoperoxide synthase by anacardic acids. Biochem Biophys Res Commun 176:775-780, 1991
10. Ha TJ, Kubo I: Lipoxygenase inhibitory activity of anacardic acids. J Agric Food Chem 53:4350-4354, 2005 (Pubitemid 40855456)
11. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427-1433, 1990 (Pubitemid 120032755)
12. Itokawa H, Totsuka N, Nakahara K, Takeya K, Lepoittevin JP, Asakawa Y: Antitumor principles from Ginkgo biloba L. Chem Pharm Bull (Tokyo) 35:3016-3020, 1987
13. Jacobson S, Pillus L: Modifying chromatin and concepts of cancer. Curr Opin Genet Dev 9:175-184, 1999 (Pubitemid 29158552)
14. Jankowska A, Wasko R, Waligorska-Stachura J, Andrusiewicz M, Jaskula M, Liebert W, et al: Survivin products in pituitary tumors. Neuroendocrinol Lett 29:1033-1037, 2008
15. Johansen PW, Haug E, Gautvik KM: Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells. Acta Endocrinol (Copenh) 110:200-206, 1985 (Pubitemid 16246299)
16. Johnson WD, Loredo LN, Slater JD: Surgery and radiotherapy: complementary tools in the management of benign intracranial tumors. Neurosurg Focus 24(5):E2, 2008
17. Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, et al: Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138:299-305, 2005 (Pubitemid 41253814)
18. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E: Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biol Reprod 62:1486-1494, 2000 (Pubitemid 30333728)
19. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL: Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74:914-919, 1992
20. King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, et al: Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 28(1):E10, 2010
21. Kreutzer J, Fahlbusch R: Diagnosis and treatment of pituitary tumors. Curr Opin Neurol 17:693-703, 2004 (Pubitemid 39613001)
22. Kubo I, Kinst-Hori I, Yokokawa Y: Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod 57:545-551, 1994 (Pubitemid 24152917)
23. Lindemann RK, Gabrielli B, Johnstone RW: Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle 3:779-788, 2004 (Pubitemid 40187911)
24. Marmorstein R: Structural and chemical basis of histone acetylation. Novartis Found Symp 259:78-101, 163-109, 2004
25. Miller M, Chen S, Woodliff J, Kansra S: Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 149:4158-4167, 2008
26. Olivera Ortega AG, Soto Hernández M, Martínez Vázquez M, Terrazas Salgado T, Solares Arenas F: Phytochemical study of cuachalalate (Amphiptherygium adstringens, Schiede ex Schlecht). J Ethnopharmacol 68:109-113, 1999 (Pubitemid 29502466)
27. Ostlund RE Jr, Leung JT, Hajek SV, Winokur T, Melman M: Acute stimulated hormone release from cultured GH3 pituitary cells. Endocrinology 103:1245-1252, 1978 (Pubitemid 9048012)
28. Pollock BE: Radiosurgery for pituitary adenomas. Prog Neurol Surg 20:164-171, 2007
29. Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER: Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443-451, 2001 (Pubitemid 34164016)
30. Rea AI, Schmidt JM, Setzer WN, Sibanda S, Taylor C, Gwebu ET: Cytotoxic activity of Ozoroa insignis from Zimbabwe. Fitoterapia 74:732-735, 2003 (Pubitemid 37443469)
31. Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, et al: Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65:4881-4887, 2005 (Pubitemid 40740827)
32. Sangeetha SR, Singh N, Vender JR, Dhandapani KM: Suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in pituitary adenoma cells. Endocrine 35:389-396, 2009
33. Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, et al: Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 16: 1339-1350, 2009
34. Shahbazian MD, Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76: 75-100, 2007
35. Shankar S, Srivastava RK: Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv Exp Med Biol 615:261-298, 2008
36. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL: Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311:844-847, 2006 (Pubitemid 43228847)
37. Sobel RE, Cook RG, Allis CD: Non-random acetylation of histone H4 by a cytoplasmic histone acetyltransferase as determined by novel methodology. J Biol Chem 269:18576-18582, 1994
38. Sun Y, Jiang X, Chen S, Price BD: Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 580:4353-4356, 2006 (Pubitemid 44137349)
39. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E III, Kooy HM, et al: Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215-221, 1993 (Pubitemid 23304445)
40. Wakade C, King MD, Laird MD, Alleyne CH Jr, Dhandapani KM: Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxid Redox Signal 11:35-45, 2009
41. Wasko R, Jankowska A, Waligorska-Stachura J, Andrusiewicz M, Jaskula M, Sowinski J: Survivin expression in pituitary adenomas. Neuroendocrinol Lett 26:209-212, 2005 (Pubitemid 40975098)
42. Wurtele H, Verreault A: Histone post-translational modifications and the response to DNA double-strand breaks. Curr Opin Cell Biol 18:137-144, 2006 (Pubitemid 43375880)
43. Zhang YC, Gao J, Xin T, Zheng ZM, Teng LZ: Expression of survivin in invasive pituitary adenoma. Saudi Med J 29: 1589-1592, 2008